Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

per Taskinen, Marja-Riitta, Borén, Jan
Publicat a Curr Atheroscler Rep (2016)

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

per Taskinen, Marja-Riitta, Packard, Chris J., Borén, Jan
Publicat a Curr Atheroscler Rep (2019)

Dietary Fructose and the Metabolic Syndrome

per Taskinen, Marja-Riitta, Packard, Chris J, Borén, Jan
Publicat a Nutrients (2019)

Causes and Consequences of Hypertriglyceridemia

per Packard, Chris J., Boren, Jan, Taskinen, Marja-Riitta
Publicat a Front Endocrinol (Lausanne) (2020)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

per Borén, Jan, Packard, Chris J., Taskinen, Marja-Riitta
Publicat a Front Endocrinol (Lausanne) (2020)

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

per Shuhei, Nakanishi, Söderlund, Sanni, Jauhiainen, Matti, Taskinen, Marja-Riitta
Publicat 2010

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

per Adiels, Martin, Mardinoglu, Adil, Taskinen, Marja-Riitta, Borén, Jan
Publicat a Front Physiol (2015)

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

per Kahri, Juhani, Soro-Paavonen, Aino, Ehnholm, Christian, Taskinen, Marja-Riitta
Publicat 2006

A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model

per Krengel, Annette, Hauth, Jan, Taskinen, Marja-Riitta, Adiels, Martin, Jirstrand, Mats
Publicat 2013

Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models

per Berglund, Martin, Adiels, Martin, Taskinen, Marja-Riitta, Borén, Jan, Wennberg, Bernt
Publicat a PLoS One (2015)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

per Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Publicat 2010

Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol

per Björnson, Elias, Adiels, Martin, Gummesson, Anders, Taskinen, Marja-Riitta, Burgess, Stephen, Packard, Chris J, Borén, Jan
Publicat a J Am Coll Cardiol (2024)

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized contr...

per Matikainen, Niina, Söderlund, Sanni, Björnson, Elias, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Taskinen, Marja‐Riitta, Borén, Jan
Publicat a Diabetes Obes Metab (2018)

Lipoprotein(a) is Markedly More Atherogenic than LDL: An Apolipoprotein B-based Genetic Analysis

per Björnson, Elias, Adiels, Martin, Taskinen, Marja-Riitta, Burgess, Stephen, Chapman, M. John, Packard, Chris J, Borén, Jan
Publicat a J Am Coll Cardiol (2024)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

per Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Publicat 2009

High-resolution population-specific recombination rates and their effect on phasing and genotype imputation

per Hassan, Shabbeer, Surakka, Ida, Taskinen, Marja-Riitta, Salomaa, Veikko, Palotie, Aarno, Wessman, Maija, Tukiainen, Taru, Pirinen, Matti, Palta, Priit, Ripatti, Samuli
Publicat a Eur J Hum Genet (2020)

Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality

per Fredriksson, Jenny, Anevski, Dragi, Almgren, Peter, Sjögren, Marketa, Lyssenko, Valeriya, Carlson, Joyce, Isomaa, Bo, Taskinen, Marja-Riitta, Groop, Leif, Orho-Melander, Marju
Publicat 2007

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol

per Yetukuri, Laxman, Söderlund, Sanni, Koivuniemi, Artturi, Seppänen-Laakso, Tuulikki, Niemelä, Perttu S., Hyvönen, Marja, Taskinen, Marja-Riitta, Vattulainen, Ilpo, Jauhiainen, Matti, Orešič, Matej
Publicat 2010

Cardiac steatosis and left ventricular function in men with metabolic syndrome

per Nyman, Kristofer, Granér, Marit, Pentikäinen, Markku O, Lundbom, Jesper, Hakkarainen, Antti, Sirén, Reijo, Nieminen, Markku S, Taskinen, Marja-Riitta, Lundbom, Nina, Lauerma, Kirsi
Publicat 2013

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

per Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Publicat 2010